Literature DB >> 31832352

The value of an "Endocarditis Team".

Piroze M Davierwala1, Mateo Marin-Cuartas1, Martin Misfeld1, Michael A Borger1.   

Abstract

Establishment of the Heart Team concept in the field of cardiovascular medicine has resulted in quality improvement in the management of heart valve disease and heart failure. Similarly, the concept of an Endocarditis Team would be important in improving outcomes in patients with infective endocarditis (IE), given it is an uncommon clinical entity with general practitioners and low-volume centers lacking sufficient experience in its management. A multidisciplinary approach can substantially reduce the still unacceptably high morbidity and mortality in patients with IE, as it allows early diagnosis and appropriate comprehensive management. Decision-making within the Endocarditis Team must follow a standard protocol that is based on current clinical guidelines for the management of IE. If surgery is indicated, it is best performed sooner than later in most instances. Communication between referring hospitals and reference centers with an established Endocarditis Team must be smooth and definite protocols for transfer to experienced endocarditis centers with surgical facilities is essential. Follow-up and outpatient care following hospital discharge is crucial due to the possibility of residual infection and risk of development of recurrent endocarditis or heart failure, particularly within the first 2 years. Patient and health-care provider education is the mainstay for the accurate implementation of the Endocarditis Team concept. The following Keynote Lecture offers an overview of the current literature supporting the multidisciplinary management of IE and addresses multiple aspects related to the Endocarditis Team, highlighting its importance and necessity for the comprehensive treatment of this complex disease. 2019 Annals of Cardiothoracic Surgery. All rights reserved.

Entities:  

Keywords:  Endocarditis Team; Infective endocarditis (IE); heart valve surgery

Year:  2019        PMID: 31832352      PMCID: PMC6892719          DOI: 10.21037/acs.2019.09.03

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  12 in total

1.  Impact of therapeutic drug monitoring of antibiotics in the management of infective endocarditis.

Authors:  G Macheda; N El Helali; G Péan de Ponfilly; M Kloeckner; P Garçon; M Maillet; V Tolsma; C Mory; A Le Monnier; B Pilmis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-08-19       Impact factor: 5.103

2.  Health-Related Quality of Life following Surgery for Native and Prosthetic Valve Infective Endocarditis.

Authors:  Shekhar Saha; Ralitsa Mladenova; Caroline Radner; Konstanze Maria Horke; Joscha Buech; Philipp Schnackenburg; Ahmad Ali; Sven Peterss; Gerd Juchem; Maximilian Luehr; Christian Hagl; Dominik Joskowiak
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

Review 3.  Blood culture negative endocarditis in the modern era of 16S rRNA sequencing.

Authors:  Rebecca Godfrey; Sally Curtis; William Hk Schilling; P Rachael James
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

4.  The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy.

Authors:  Boaz Elad; Leor Perl; Ashraf Hamdan; Dafna Yahav; Alaa Atamna; Hila Shaked; Victor Rubchevsky; Ram Sharony; Hanna Bernstine; Yaron Shapira; Mordehay Vaturi; Hadas Ofek; Alexander Sagie; Ran Kornowski; Katia Orvin
Journal:  Infection       Date:  2021-06-05       Impact factor: 3.553

Review 5.  Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications.

Authors:  Francesco Pollari; Cristiano Spadaccio; Michela Cuomo; Massimo Chello; Antonio Nenna; Theodor Fischlein; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

6.  Non-toxigenic Corynebacterium diphtheriae infective endocarditis with embolic events: a case report.

Authors:  Antonio de Santis; Rinaldo Focaccia Siciliano; Roney Orismar Sampaio; Masahiko Akamine; Elinthon T Veronese; Francisco Monteiro de Almeida Magalhaes; Maria Rita Elmor Araújo; Flavia Rossi; Marcelo M C Magri; Ana Catharina Nastri; Tarso A D Accorsi; Vitor E E Rosa; David Provenzale Titinger; Guilherme S Spina; Flavio Tarasoutchi
Journal:  BMC Infect Dis       Date:  2020-12-01       Impact factor: 3.090

Review 7.  Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association/American College of Cardiology and European Society of Cardiology guidelines.

Authors:  Umberto Maria Satriano; Antonio Nenna; Cristiano Spadaccio; Francesco Pollari; Theodor Fischlein; Massimo Chello; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

8.  Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospital.

Authors:  A I Peláez Ballesta; E García Vázquez; J Gómez Gómez
Journal:  Rev Esp Quimioter       Date:  2021-11-30       Impact factor: 1.553

9.  Blood Cultures for the Diagnosis of Infective Endocarditis: What Is the Benefit of Prolonged Incubation?

Authors:  Vincent Fihman; Hélène Faury; Amina Moussafeur; Raphaelle Huguet; Adrien Galy; Sébastien Gallien; Pascal Lim; Raphaël Lepeule; Paul-Louis Woerther
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

10.  Outcomes and Risk Factors of Septic Shock in Patients With Infective Endocarditis: A Prospective Cohort Study.

Authors:  Juan M Pericàs; Marta Hernández-Meneses; Patricia Muñoz; Ana Álvarez-Uría; Blanca Pinilla-Llorente; Arístides de Alarcón; Karlos Reviejo; M Carmen Fariñas; Carlos Falces; Josune Goikoetxea-Agirre; Juan Gálvez-Acebal; Carmen Hidalgo-Tenorio; Eloy Gómez-Nebreda; Jose M Miro
Journal:  Open Forum Infect Dis       Date:  2021-03-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.